In 2018, anticipated first generics include agents for central nervous system, dermatologic, and urologic disease and anti-inflammatory and antiretroviral agents, among others.
Because these agents account for an estimated 89% to 90% of the prescriptions dispensed annually in the United States, it is imperative that pharmacists be able to authoritatively address patient questions about the genesis of generic medications.